/Investor DB

Kindred Capital — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Dash Biodash.bioinSeed · Oct 2024 · $7M

Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days.

AI & Machine LearningBiotechHealthtechRoboticsBoston, US

Dave Johnson(Co-founder & CEO)inAlexander Tallett(Executive Officer, Director)

BoardAndy Smith(Director)in

Co-investorsCompanion M Gmb HCybernetix VenturesFreestyle CapitalLifeX VenturesOak HC/FTSwift Ventures+1 more

Duniadunia.aiin𝕏Oct 2024

Dunia operates an autonomous laboratory platform that combines physics-informed AI, robotic automation, and a large-scale experimental data engine in a closed-loop Design-Make-Test-Analyze cycle to discover and optimize materials such as electrochemical catalysts.

AI & Machine LearningDeep TechNew Materials

Marcus Tze-Kiat Ng(Founder)in

Co-investorsDeep Science VenturesElaiaPace VenturesThird DerivativeEICredalpine

Fractilefractile.aiinJul 2024

Fractile designs processors for AI acceleration, offering the next generation of computing hardware.

AI & Machine LearningDeep TechHardwareSemiconductorsBristol, GB

Walter Goodwin(Founder & CEO)in

Co-investors01 AdvisorsAccelFactorial FundsFelicis VenturesGigascale CapitalInovia Capital+10 more

Shift Bioscienceshiftbioscience.comin𝕏Oct 2024 · $16M

Shift Bioscience develops siRNA therapeutics for cell rejuvenation, using a target identification platform that has identified an anti-fibrotic candidate initially aimed at liver fibrosis.

AI & Machine LearningBiotechLongevityCambridge, GB

Daniel Ives(Founder & CEO)inBrendan Swain(Co-founder & CSO)in

Co-investorsF-Prime CapitalIKJ CapitalCambridge Innovation Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.